|
Vepalimomab
|
維帕莫單抗
|
195158-85-1
|
|
Fezakinumab
|
非扎奴單抗
|
1007106-86-6
|
|
Ensituximab
|
恩妥昔單抗
|
1092658-06-4
|
|
Teprotumumab
|
替妥木單抗
|
1036734-93-6
|
|
Mavrilimumab
|
瑪弗利木單抗
|
1085337-57-0
|
|
Morolimumab
|
莫羅木單抗
|
|
|
Faralimomab
|
法拉莫單抗
|
167816-91-3
|
|
Enokizumab
|
依諾凱組單抗
|
909875-08-7
|
|
Etrolizumab
|
依曲利組單抗
|
1044758-60-2
|
|
Atinumab
|
阿替奴單抗
|
1226761-65-4
|
|
Carlumab
|
卡蘆單抗
|
915404-94-3
|
|
Rontalizumab
|
隆利組單抗
|
948570-30-7
|
|
Girentuximab
|
吉妥昔單抗
|
916138-87-9
|
|
Suvizumab
|
舒維組單抗
|
914257-21-9
|
|
Bectumomab
|
貝妥莫單抗
|
158318-63-9
|
|
Minretumomab
|
明瑞莫單抗
|
195189-17-4
|
|
Nerelimomab
|
奈瑞莫單抗
|
162774-06-3
|
|
Mogamulizumab
|
莫格利組單抗
|
1159266-37-1
|
|
Icrucumab
|
艾蘆庫單抗
|
1024603-92-6
|
|
Fulranumab
|
福拉奴單抗
|
902141-80-4
|
|
Rovelizumab
|
羅維珠單抗
|
339086-79-2
|
|
Enavatuzumab
|
依那妥組單抗
|
1062149-33-0
|
|
Dalotuzumab
|
達羅托組單抗
|
1005389-60-5
|
|
Itolizumab
|
伊利組單抗
|
1116433-11-4
|
|
Glembatumumab
|
格巴妥木單抗
|
1020264-78-1
|
|
Lebrikizumab
|
來瑞組單抗
|
953400-68-5
|
|
Intetumumab
|
英妥木單抗
|
725735-28-4
|
|
Foralumab
|
福雷蘆單抗
|
946415-64-1
|
|
Drozitumab
|
曲齊妥單抗
|
912628-39-8
|
|
Samalizumab
|
沙馬組單抗
|
1073059-33-2
|
|
Ozoralizumab
|
奧利組單抗
|
1167985-17-2
|
|
Pateclizumab
|
帕替組單抗
|
1202526-59-7
|
|
Sirukumab
|
西魯庫單抗
|
1194585-53-9
|
|
AMG-131
|
|
315224-26-1
|
|
Apostatin-1
|
|
2559703-06-7
|
|
NCC007
|
|
2342583-66-6
|
|
AZ32
|
|
2288709-96-4
|
|
Onartuzumab
|
奧那妥組單抗
|
1133766-06-9
|
|
Ponezumab
|
泊奈組單抗
|
1178862-65-1
|
|
Quilizumab
|
奎利珠單抗
|
1228538-47-3
|
|
Radretumab
|
雷曲妥單抗
|
1253180-81-2
|
|
Tregalizumab
|
曲利組單抗
|
1207446-68-1
|
|
Ublituximab
|
烏妥昔單抗
|
1174014-05-1
|
|
Urelumab
|
烏瑞蘆單抗
|
934823-49-1
|
|
Caplacizumab
|
卡拉西單抗
|
915810-67-2
|
|
Solitomab
|
索利托單抗
|
1005198-65-1
|
|
Flanvotumab
|
法蘭妥單抗
|
1188277-05-5
|
|
Vatelizumab
|
伐利組單抗
|
1238217-55-4
|
|
Tabalumab
|
他貝蘆單抗
|
1143503-67-6
|
|
Ficlatuzumab
|
非拉妥組單抗
|
1174900-84-5
|
|
Narnatumab
|
那吶妥單抗
|
1188275-92-4
|
|
Crenezumab
|
克瑞組單抗
|
1095207-05-8
|
|
Blosozumab
|
布索組單抗
|
1132758-87-2
|
|
Clazakizumab
|
克拉扎珠單抗
|
1236278-28-6
|
|
Fasinumab
|
法司努單抗
|
1190239-42-9
|
|
Enoticumab
|
依諾蘇單抗
|
1192578-27-0
|
|
Duligotuzumab
|
度戈妥珠單抗
|
1314238-96-4
|
|
Demcizumab
|
登賽珠單抗
|
1243262-17-0
|
|
Vesencumab
|
維森庫單抗
|
1205533-60-3
|
|
Indatuximab Ravtansine
|
雷英妥昔單抗
|
1238517-16-2
|
|
Nemolizumab
|
奈莫利珠單抗
|
1476039-58-3
|
|
Lirilumab
|
利瑞魯單抗
|
1000676-41-4
|
|
Tesidolumab
|
特度魯單抗
|
1531594-08-7
|
|
Futuximab
|
伏妥昔單抗
|
1310460-85-5
|
|
Imgatuzumab
|
伊馬曲單抗
|
959963-46-3
|
|
Ligelizumab
|
利格利珠單抗
|
1322627-61-1
|
|
Actoxumab
|
阿克托舒單抗
|
1245634-25-6
|
|
Vandortuzumab Vedotin
|
維汀-萬多妥珠單抗
|
1471985-92-8
|
|
Evinacumab
|
依維蘇單抗
|
1446419-85-7
|
|
Lokivetmab
|
洛吉維單抗
|
1533403-95-0
|
|
Tafasitamab
|
|
1422527-84-1
|
|
Isatuximab
|
艾薩妥昔單抗
|
1461640-62-9
|
|
Lacutamab
|
拉可妥單抗
|
2187368-16-5
|
|
Andecaliximab
|
安德利昔單抗
|
1518996-49-0
|
|
Amivantamab
|
埃萬妥單抗
|
2171511-58-1
|
|
Indusatumab Vedotin
|
|
1514889-12-3
|
|
Mc-Val-Ala-PAB-PNP
|
|
1639939-40-4
|
|
YTX-465
|
|
2225824-53-1
|
|
SR1664
|
|
1338259-05-4
|
|
RY785
|
|
1393748-80-5
|
|
AZD-1940
|
|
881413-29-2
|
|
GI 181771
|
|
305366-98-7
|
|
JQKD-82
|
|
2410512-38-6
|
|
SCD1 inhibitor-3
|
|
1282606-48-7
|
|
Bocidelpar
|
|
2095128-20-2
|
|
SUC-ALA-ALA-PRO-PHE-PNA
|
|
107409-54-1
|
|
Bezlotoxumab
|
貝洛托舒單抗
|
1246264-45-8
|
|
Dectrekumab
|
德屈庫單抗
|
1528523-94-5
|
|
Inclacumab
|
|
1256258-86-2
|
|
NCGC00378430
|
|
920650-00-6
|
|
2,4-Dichlorophenoxyacetyl chloride
|
2,4-二氯苯氧乙酰氯
|
774-74-3
|
|
Biotinyl Cystamine
|
生物素半胱胺
|
128915-82-2
|
|
(R)-GSK-3685032
|
|
2170140-50-6
|
|
Maslimomab
|
馬司莫單抗
|
127757-92-0
|
|
INE963
|
|
2640567-43-5
|
|
JYN42346
|
|
1903742-34-6
|
|
ML339
|
|
2579689-83-9
|
|
Patritumab
|
帕曲妥單抗
|
1262787-83-6
|
|
Altumomab
|
阿妥莫單抗
|
156586-92-4
|
|
Sifalimumab
|
西法木單抗
|
1006877-41-3
|